Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg
Jun 01, 2021
Mumbai (Maharashtra) [India], June 1 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has launched Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of...